Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BabyCCINO: Caffeine Citrate for Apnea of Prematurity
NCT06972849Not yet recruiting
- Sponsor
- University of Melbourne
- Start
- Oct 2025
- Primary completion
- Dec 2029
- Modality
- Small Molecules
01
Overview
Randomised, triple-blind trial of caffeine in apnea of prematurity (AOP) (3 arms), sponsored by University of Melbourne. Primary endpoint: PLATIPUS Ordinal Outcome Scale. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
caffeine
03
Conditions
apnea of prematurity (AOP)
Beyond the preview
Go deeper on NCT06972849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06972849.